Lexeo Therapeutics, Inc. Common Stock (LXEO) Earnings
Lexeo Therapeutics, Inc. Common Stock is expected to report next earnings on August 13, 2026 (in NaN days), with a consensus EPS estimate of $-0.31. LXEO has beaten EPS estimates in 5 of its last 8 reported quarters (average surprise +16.7% over the last four).
Next earnings
Aug 13, 2026in NaN days
EPS est $-0.31 · Revenue est —
Track record
Beat EPS in 5 of 8 quarters
Avg surprise +16.7% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 11, 2026 | $-0.29 | $-0.25 | +13.8% | — | — |
| Mar 30, 2026 | $-0.32 | $-0.27 | +15.6% | — | — |
| Nov 5, 2025 | $-0.48 | $-0.33 | +31.2% | — | — |
| Aug 14, 2025 | $-0.64 | $-0.60 | +6.3% | — | — |
| Mar 24, 2025 | $-0.87 | $-0.78 | +10.3% | — | — |
| Nov 13, 2024 | $-0.65 | $-0.89 | -36.9% | — | — |
| May 9, 2024 | $-0.76 | $-0.77 | -1.3% | — | — |
| Mar 11, 2024 | $-0.73 | $-0.85 | -16.4% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.